These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1137 related articles for article (PubMed ID: 11980651)

  • 1. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.
    Liao F; Li Y; O'Connor W; Zanetta L; Bassi R; Santiago A; Overholser J; Hooper A; Mignatti P; Dejana E; Hicklin DJ; Bohlen P
    Cancer Res; 2000 Dec; 60(24):6805-10. PubMed ID: 11156369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature.
    May C; Doody JF; Abdullah R; Balderes P; Xu X; Chen CP; Zhu Z; Shapiro L; Kussie P; Hicklin DJ; Liao F; Bohlen P
    Blood; 2005 Jun; 105(11):4337-44. PubMed ID: 15701713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation.
    Li H; Shi X; Liu J; Hu C; Zhang X; Liu H; Jin J; Opolon P; Vannier JP; Perricaudet M; Janin A; Soria C; Lu H
    Cancer Gene Ther; 2010 Oct; 17(10):700-7. PubMed ID: 20559333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
    Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.
    Menon C; Ghartey A; Canter R; Feldman M; Fraker DL
    Ann Surg; 2006 Nov; 244(5):781-91. PubMed ID: 17060772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.
    Corada M; Zanetta L; Orsenigo F; Breviario F; Lampugnani MG; Bernasconi S; Liao F; Hicklin DJ; Bohlen P; Dejana E
    Blood; 2002 Aug; 100(3):905-11. PubMed ID: 12130501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of endothelial barrier function during normal angiogenesis requires homotypic VE-cadherin adhesion.
    DeFouw LM; DeFouw DO
    Tissue Cell; 2000 Jun; 32(3):238-42. PubMed ID: 11037794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability.
    Fainaru O; Adini I; Benny O; Bazinet L; Pravda E; D'Amato R; Folkman J
    FASEB J; 2008 Oct; 22(10):3728-35. PubMed ID: 18606869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
    Li J; Huang S; Armstrong EA; Fowler JF; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1477-85. PubMed ID: 16029810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis.
    Lampugnani MG; Dejana E
    Thromb Res; 2007; 120 Suppl 2():S1-6. PubMed ID: 18023702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
    Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
    Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cadherins and tumor angiogenesis.
    Cavallaro U; Liebner S; Dejana E
    Exp Cell Res; 2006 Mar; 312(5):659-67. PubMed ID: 16256984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability.
    Dejana E; Lampugnani MG; Martinez-Estrada O; Bazzoni G
    Int J Dev Biol; 2000; 44(6):743-8. PubMed ID: 11061439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
    Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.